Developer docs
API playgroundTry for free, no card

Search company profiles

TUUS

Full company profile

uuid003w495

Namestring
TUUS
Legal namestring
TUUS Solutions Sarl
Company typeenum
Private
Founded yearint
2025
Descriptiontext

TUUS Nutrition Labs is an EPFL spin-off foodtech startup headquartered in Lausanne, Switzerland, developing HyCORE, a patent-pending plant-based hydrogel platform for the controlled oral delivery of nutrients and active compounds. The technology enables zero-order, constant-rate release kinetics with adjustable duration, uses 100% plant-based materials (no synthetic polymers, no animal products), and is described as scalable to ton-scale production using common infrastructure at costs competitive with commodity delivery systems.

The company's first commercial application is TUUS Energy Gel, a sustained-energy gel for endurance athletes designed to address sugar spikes, stomach discomfort, and uneven energy delivery. Beyond the energy gel, TUUS has articulated a pipeline spanning metabolic health (sugar management for diabetes and clinical nutrition), medical nutrition (sustained supplementation to eliminate dose-related spike-and-crash effects), and a longer-term vision of applying HyCORE to oral drug delivery for commodity pharmaceuticals.

TUUS operates a hybrid commercial model: a B2B licensing GTM targeting leading nutrition and healthcare players as anchor partners for the HyCORE platform, alongside direct e-commerce distribution of its energy gel. As of mid-2026 the company is pre-revenue, with approximately CHF 150,000 in disclosed Venture Kick grant funding, a 1–10 person team, and a patent-pending IP position, making it an early-stage platform licensing play rather than a commercial product business at this stage.

Short descriptiontext

TUUS Nutrition Labs is an EPFL spin-off developing HyCORE, a patent-pending plant-based hydrogel platform for zero-order delivery of nutrients and active compounds. It licenses the technology to nutrition and healthcare players and sells an energy gel for endurance athletes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLausanne, Switzerland
HQ citystring
Lausanne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
controlled-release hydrogels, oral drug delivery, plant-based nutrition, energy gels, B2B platform licensing
Industry2 codes
1Gelling Agents & Systems (Gelatin, Agar, Gellan, Konjac)
CodeAFAJACAHPrimaryYes
2Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support)
CodeAFADALAOPrimaryNo
NAICS code1 code
  • Animal Food Manufacturing3111
SIC code3 codes
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
Product category
Controlled-release hydrogel technology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Licensing
TypeLicensing Royalties
Description

Licensing the HyCORE platform technology to leading nutrition and healthcare players. The company grants access to their patent-pending hydrogel technology for partners to develop and commercialize products in their respective markets.

startupticker.ch
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1HyCORE™
Description

Patent-pending plant-based hydrogel platform enabling precise, constant-rate (zero-order) delivery of active compounds. Plant-based, scalable to ton-scale production, and cost-competitive with commodity delivery systems.

tuusnutrition.ch
Core offering1 text field

TUUS has developed HyCORE™, a patent-pending plant-based hydrogel platform that enables precise, constant-rate (zero-order) delivery of active compounds through oral administration. The company operates a B2B licensing model, granting enterprise partners in nutrition and healthcare access to the platform to develop and commercialize products in sports nutrition, clinical nutrition, metabolic health, and pharmaceuticals. Its first commercial application is the TUUS Energy Gel, a sustained-energy hydrogel product for endurance athletes that demonstrates HyCORE™ at market scale.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Constant-rate delivery eliminates sugar spikes and provides steady energy for endurance athletes
Product overview1 text field

TUUS offers a platform-plus-products architecture built around HyCORE™, a patent-pending plant-based hydrogel platform for controlled delivery of nutrients and active compounds. The core HyCORE™ platform enables zero-order constant-rate delivery with 100% plant-based composition that is scalable and cost-competitive. The first commercial product is TUUS Energy Gel, applying HyCORE™ technology to sustained energy delivery for endurance athletes. The product pipeline extends HyCORE™ into three verticals: Sugar Management (Metabolic Health), Medical Nutrition (Sustained Supplementation), and Oral Drug Delivery — all leveraging the same underlying hydrogel technology through a B2B licensing model targeting nutrition and healthcare players.

Product and service2 records
1HyCORE™ Platform
CategoryHydrogel delivery technology platform
Description

Patent-pending plant-based hydrogel platform enabling precise, constant-rate (zero-order) controlled delivery of active compounds for applications in sports nutrition, clinical nutrition, and oral drug delivery. Features 100% plant-based composition with no synthetic polymers or animal products, and is scalable to ton-scale production using common infrastructure. Licensed to enterprise partners in nutrition and healthcare.

2TUUS Energy Gel
CategorySports nutrition product
Description

Sustained-energy hydrogel gel for endurance athletes, serving as the first commercial demonstration of HyCORE™ hydrogel technology. Targets athletes who experience sugar spikes, stomach discomfort, and uneven energy delivery with conventional gels.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Rousselot is a global leader in gelatin-based gelling and delivery systems for food, nutrition, and pharma. Its expertise in gel-forming biomaterials directly parallels HyCORE™'s plant-based hydrogel positioning.

TypeBroad incumbent
Description

Lonza is a global contract development and manufacturing organization with deep capabilities in oral drug delivery, capsules, and controlled-release formulations. It represents a comparable platform for the pharmaceutical expansion of HyCORE™ and a likely enterprise partner target.

TypeBroad incumbent
Description

Ingredion is a global ingredient solutions provider with extensive capabilities in plant-based hydrocolloids and texturizing systems. Its portfolio overlaps with TUUS's hydrogel platform and represents both a potential partner and competitive threat.

TypeDirect peer
Description

SiS is a sports nutrition brand with a strong endurance gel and hydration portfolio targeting the same athlete personas. Its recent acquisition by Sunshine Yangshengtang demonstrates the strategic value of endurance nutrition brands.

TypeDirect peer
Description

Maurten pioneered hydrogel-based sports nutrition for endurance athletes using a similar biopolymer hydrogel delivery system. It is the closest direct competitor to TUUS Energy Gel and demonstrates the commercial viability of hydrogel technology in endurance sports.

TypeDirect peer
Description

GU is the dominant incumbent in the endurance energy gel category that TUUS is entering. It represents the brand-driven, distribution-heavy competitive benchmark TUUS must displace or differentiate from at the consumer level.

TypeBroad incumbent
Description

Evonik is a specialty chemicals company with a strong drug delivery and controlled-release excipients portfolio. It is comparable as both a potential HyCORE™ pharmaceutical licensee and as a competitor in controlled-release oral delivery.

TypeDirect peer
Description

Honey Stinger is a leading natural-ingredient energy gel and chews brand in endurance nutrition. It competes head-to-head with TUUS in the same retail and athlete channels, particularly in the natural/clean-label positioning TUUS emphasizes.

TypeBroad incumbent
Description

DSM-Firmenich is a global nutrition, health, and ingredients powerhouse with deep expertise in functional food ingredients and drug delivery. It is the type of large strategic partner TUUS's B2B licensing model targets, and a likely competitor in any controlled-release nutrition pipeline.

TypeBroad incumbent
Description

Tate & Lyle is a major food ingredients company with a controlled-release and texture/specialty ingredients portfolio. It could be both a potential licensee for HyCORE™ and a competitor in gelling/hydrocolloid systems used in nutrition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TUUS

Controlled-release hydrogel technologytuusnutrition.ch

TUUS Nutrition Labs is an EPFL spin-off developing HyCORE, a patent-pending plant-based hydrogel platform for zero-order delivery of nutrients and active compounds. It licenses the technology to nutrition and healthcare players and sells an energy gel for endurance athletes.

What TUUS does

TUUS Nutrition Labs is an EPFL spin-off foodtech startup headquartered in Lausanne, Switzerland, developing HyCORE, a patent-pending plant-based hydrogel platform for the controlled oral delivery of nutrients and active compounds. The technology enables zero-order, constant-rate release kinetics with adjustable duration, uses 100% plant-based materials (no synthetic polymers, no animal products), and is described as scalable to ton-scale production using common infrastructure at costs competitive with commodity delivery systems.

The company's first commercial application is TUUS Energy Gel, a sustained-energy gel for endurance athletes designed to address sugar spikes, stomach discomfort, and uneven energy delivery. Beyond the energy gel, TUUS has articulated a pipeline spanning metabolic health (sugar management for diabetes and clinical nutrition), medical nutrition (sustained supplementation to eliminate dose-related spike-and-crash effects), and a longer-term vision of applying HyCORE to oral drug delivery for commodity pharmaceuticals.

TUUS operates a hybrid commercial model: a B2B licensing GTM targeting leading nutrition and healthcare players as anchor partners for the HyCORE platform, alongside direct e-commerce distribution of its energy gel. As of mid-2026 the company is pre-revenue, with approximately CHF 150,000 in disclosed Venture Kick grant funding, a 1–10 person team, and a patent-pending IP position, making it an early-stage platform licensing play rather than a commercial product business at this stage.

TUUS firmographics

Firmographics
Name
TUUS
Legal name
TUUS Solutions Sarl
Website
https://tuusnutrition.ch
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
TUUS Nutrition Labs is an EPFL spin-off developing HyCORE, a patent-pending plant-based hydrogel platform for zero-order delivery of nutrients and active compounds. It licenses the technology to nutrition and healthcare players and sells an energy gel for endurance athletes.
Ownership category
akta.pro rank

TUUS industry classification

Industry
Product category
Controlled-release hydrogel technology
NAICS
Animal Food Manufacturing (3111)
SIC
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Gelling Agents & Systems (Gelatin, Agar, Gellan, Konjac) (AFAJACAH)
akta.pro secondary industry
Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)

Keywords

  • Controlled-release hydrogels
  • Oral drug delivery
  • Plant-based nutrition
  • Energy gels
  • B2B platform licensing

Where TUUS is headquartered

Location

Headquarters

HQ city
Lausanne
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

TUUS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

  1. B2B Licensing: Licensing the HyCORE platform technology to leading nutrition and healthcare players. The company grants access to their patent-pending hydrogel technology for partners to develop and commercialize products in their respective markets.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

TUUS product offering

Product offering

Core offering

TUUS has developed HyCORE™, a patent-pending plant-based hydrogel platform that enables precise, constant-rate (zero-order) delivery of active compounds through oral administration. The company operates a B2B licensing model, granting enterprise partners in nutrition and healthcare access to the platform to develop and commercialize products in sports nutrition, clinical nutrition, metabolic health, and pharmaceuticals. Its first commercial application is the TUUS Energy Gel, a sustained-energy hydrogel product for endurance athletes that demonstrates HyCORE™ at market scale.

Product overview

TUUS offers a platform-plus-products architecture built around HyCORE™, a patent-pending plant-based hydrogel platform for controlled delivery of nutrients and active compounds. The core HyCORE™ platform enables zero-order constant-rate delivery with 100% plant-based composition that is scalable and cost-competitive. The first commercial product is TUUS Energy Gel, applying HyCORE™ technology to sustained energy delivery for endurance athletes. The product pipeline extends HyCORE™ into three verticals: Sugar Management (Metabolic Health), Medical Nutrition (Sustained Supplementation), and Oral Drug Delivery — all leveraging the same underlying hydrogel technology through a B2B licensing model targeting nutrition and healthcare players.

Differentiator

Problem solved

Functional benefit

Brands

  • HyCORE™: Patent-pending plant-based hydrogel platform enabling precise, constant-rate (zero-order) delivery of active compounds. Plant-based, scalable to ton-scale production, and cost-competitive with commodity delivery systems.

Products and services

  • HyCORE™ Platform Patent-pending plant-based hydrogel platform enabling precise, constant-rate (zero-order) controlled delivery of active compounds for applications in sports nutrition, clinical nutrition, and oral drug delivery. Features 100% plant-based composition with no synthetic polymers or animal products, and is scalable to ton-scale production using common infrastructure. Licensed to enterprise partners in nutrition and healthcare.
  • TUUS Energy Gel Sustained-energy hydrogel gel for endurance athletes, serving as the first commercial demonstration of HyCORE™ hydrogel technology. Targets athletes who experience sugar spikes, stomach discomfort, and uneven energy delivery with conventional gels.

Quantifiable outcome

  • Constant-rate delivery eliminates sugar spikes and provides steady energy for endurance athletes

Companies that use TUUS

Customer profile

Segments4 records

Ideal customer profiles2 records

TUUS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature4 records

TUUS partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

TUUS competitors and assessment

Company assessment

Broad incumbents

  • Rousselot (Darling Ingredients): Rousselot is a global leader in gelatin-based gelling and delivery systems for food, nutrition, and pharma. Its expertise in gel-forming biomaterials directly parallels HyCORE™'s plant-based hydrogel positioning.
  • Lonza: Lonza is a global contract development and manufacturing organization with deep capabilities in oral drug delivery, capsules, and controlled-release formulations. It represents a comparable platform for the pharmaceutical expansion of HyCORE™ and a likely enterprise partner target.
  • Ingredion: Ingredion is a global ingredient solutions provider with extensive capabilities in plant-based hydrocolloids and texturizing systems. Its portfolio overlaps with TUUS's hydrogel platform and represents both a potential partner and competitive threat.
  • Evonik: Evonik is a specialty chemicals company with a strong drug delivery and controlled-release excipients portfolio. It is comparable as both a potential HyCORE™ pharmaceutical licensee and as a competitor in controlled-release oral delivery.
  • DSM-Firmenich: DSM-Firmenich is a global nutrition, health, and ingredients powerhouse with deep expertise in functional food ingredients and drug delivery. It is the type of large strategic partner TUUS's B2B licensing model targets, and a likely competitor in any controlled-release nutrition pipeline.
  • Tate & Lyle: Tate & Lyle is a major food ingredients company with a controlled-release and texture/specialty ingredients portfolio. It could be both a potential licensee for HyCORE™ and a competitor in gelling/hydrocolloid systems used in nutrition.

Direct peers

  • Science in Sport (SiS): SiS is a sports nutrition brand with a strong endurance gel and hydration portfolio targeting the same athlete personas. Its recent acquisition by Sunshine Yangshengtang demonstrates the strategic value of endurance nutrition brands.
  • Maurten: Maurten pioneered hydrogel-based sports nutrition for endurance athletes using a similar biopolymer hydrogel delivery system. It is the closest direct competitor to TUUS Energy Gel and demonstrates the commercial viability of hydrogel technology in endurance sports.
  • GU Energy Labs: GU is the dominant incumbent in the endurance energy gel category that TUUS is entering. It represents the brand-driven, distribution-heavy competitive benchmark TUUS must displace or differentiate from at the consumer level.
  • Honey Stinger: Honey Stinger is a leading natural-ingredient energy gel and chews brand in endurance nutrition. It competes head-to-head with TUUS in the same retail and athlete channels, particularly in the natural/clean-label positioning TUUS emphasizes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

TUUS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TUUS leadership team

Management profile

Number of profiles

TUUS funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TUUS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TUUS

What does TUUS do?

TUUS has developed HyCORE™, a patent-pending plant-based hydrogel platform that enables precise, constant-rate (zero-order) delivery of active compounds through oral administration. The company operates a B2B licensing model, granting enterprise partners in nutrition and healthcare access to the platform to develop and commercialize products in sports nutrition, clinical nutrition, metabolic health, and pharmaceuticals. Its first commercial application is the TUUS Energy Gel, a sustained-energy hydrogel product for endurance athletes that demonstrates HyCORE™ at market scale.

Is TUUS a public or private company?

TUUS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TUUS founded?

TUUS was founded in 2025. It employs 1 to 10 people.

Where is TUUS based?

TUUS is headquartered in Lausanne, Switzerland, in the Europe region.

How does TUUS make money?

One revenue line is on record: B2B Licensing.

Who are TUUS's main competitors?

Broad incumbents on record are Rousselot (Darling Ingredients), Lonza, Ingredion, Evonik, DSM-Firmenich and Tate & Lyle. Direct peers are Science in Sport (SiS), Maurten, GU Energy Labs and Honey Stinger.

Does TUUS have an API?

No public API is recorded for TUUS.

What industry is TUUS in?

TUUS's product category is Controlled-release hydrogel technology. Its primary akta.pro industry code is AFAJACAH, Gelling Agents & Systems (Gelatin, Agar, Gellan, Konjac), with a secondary code of AFADALAO, Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support). Its NAICS code is 3111 and its SIC code is 2840.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Fondation-fitDETECTRA, TUUS Solutions, and Anyway Systems each receive a Tech Seed loanDetectra, TUUS Solutions, and Anyway Systems each received a 100,000 CHF Tech Seed loan from FIT. Detectra develops a smartphone-based platform to monitor joint inflammation, TUUS Solutions creates a food hydrogel for controlled nutrient release, and Anyway Systems offers an AI infrastructure platform. The loans will support market entry, pilot production, and client deployments.BioAlpsDETECTRA and TUUS Solutions Receive a FIT SupportThe Foundation for Innovation and Technology granted CHF 100,000 Tech Seed loans to DETECTRA and TUUS Solutions. DETECTRA will develop a smartphone-based remote monitoring platform for joint inflammation, while TUUS Solutions will advance its food-grade hydrogel for controlled nutrient release. Both startups will use the funds for market preparation and pilot projects.startupticker.chTUUS awarded CHF 150,000 from Venture KickEPFL foodtech startup TUUS has received CHF 150,000 from Venture Kick to advance HyCORE, its patent-pending plant-based hydrogel platform designed for the constant-rate controlled release of nutrients and active compounds in applications from sports nutrition to pharmaceuticals. The technology addresses issues of sugar spikes, stomach discomfort, and uneven energy delivery in endurance athletes, initially targeting the energy gel market estimated at around USD 1 billion in 2025 before expanding into clinical nutrition and diabetes management valued at around USD 60 billion in 2025. The funding will accelerate partner discussions, co-development projects, and team growth through a B2B licensing model targeting leading nutrition and healthcare players.Venture KickCHF 10,000 for an innovative instrument for food and product screening, a novel diagnostics based on single-molecule nanofluidics, next-gen quantum computers, a breakthrough edible hydrogel platform,Venture Kick selected five startups—Chromnil, MOLECL, Qendra, Tuus, and Vulkn Energy—at its first funding and entrepreneurial support stage, with each company receiving CHF 10,000. The startups are developing technologies spanning high-performance thin-layer chromatography for food safety screening, single-molecule nanofluidics for medical diagnostics, quantum computing control systems, edible hydrogel platforms for sports nutrition, and industrial thermal energy storage. The funding is intended to support product development, customer engagement, and market entry for each respective company.